With the enthusiastic support of six important partner institutions, Hannover Medical School (MHH) established the research network in the area of Regenerative Biology and Reconstructive Therapies, acronym REBIRTH.
REBIRTH was funded as a cluster of excellence within the framework of the federal and state excellence initiative from 2006 to 2019 and now continues as ‘REBIRTH – Research Center for Translational Regenerative Medicine‘.
The aim of REBIRTH is to develop new therapies for severe congenital or acquired diseases of the heart, lungs, liver and blood.
From Special Lectures, to Mariensee Talks, Conferences, Symposia, Colloquia, Young Scientists Fairs and Final Exams. Here you will find an overview of all REBIRTH events.
Since the beginning of 2009, we have regularly published our newsletter ‘REBIRTH News’ in German and English, in which selected examples of our scientific work and achieved results are presented.
From Alpharetroviral-mediated cell modification for regenerative gene therapy to Biliary cells in liver regeneration and repair.
The PIs (Principle Investigators) at REBIRTH pursue their research activities with the help of a wide range of funding.
An overview of our core projects
An overview of our synergy projects
